Founded in 2001, JenKem Technology specializes in commercial manufacture, research, development, and custom synthesis, of high-quality polyethylene glycol (PEG) derivatives, PEG co-polymers, and monodisperse PEGs.

JenKem Technology supplies high quality PEG derivatives worldwide, from R&D through GMP commercial quantities, for preclinical studies, clinical trials, and commercial products for pharma, biotech, medical devices, and diagnostics.

Additionally, JenKem Technology offers PEGylation services for oligonucleotides, peptides, proteins, and small molecules, up to preclinical stage. JenKem Technology can coordinate the IND enabling preclinical study data for PEGylated compounds together with partner CROs, to determine the optimal PEGylated compounds for customers’ application.

JenKem Technology also manufactures lipid nanoparticle (LNP) components for advanced drug delivery, including products supported by DMF registrations with the US FDA and China CDE. Capabilities include:

• GMP-scale production of ionizable lipids, PEG lipids, helper lipids, and other custom lipids
• Development of innovative LNP systems (including multi-component formulations for nucleic acid delivery)
• Contract development and manufacturing services (process development, GMP production, quality research, and DMF support)
• RNA encapsulation
• Analytical testing for LNP, RNA, and LNP-RNA systems.

In addition, JenKem Technology produces fatty acid side chain compounds from lab to GMP commercial scale (10–100 kg/batch), along with custom synthesis and molecular coupling services. The company operates under ISO 9001 and ISO 13485 certifications and follows ICH Q7 guidelines for GMP manufacturing.

Please contact us at sales@jenkemusa.com or visit our website https://www.jenkemusa.com for more information about our PEG products and PEGylation services.